Argos Therapeutics, Inc. (NASDAQ:ARGS) Quarterly EPS Estimate At $-0.29

0

The EPS estimate of Argos Therapeutics, Inc. (NASDAQ:ARGS) for period quarter ended 2016-12-31 is $-0.29.

The EPS estimates posted seven and 30 days ago were $-0.29 and $-0.29 correspondingly. Even though the EPS forecasts stated 60 and 90 days ago were $-0.29 and $-0.29 respectively. The deviation in EPS forecast from 7 days ago is 0%.

The EPS revisions on positive side in the last 7 days were 0 and downside revisions were 0. The number of positive revisions of EPS in the last 30 and 60days were 0 and 3 respectively, while for 90 and 120 days, the count was 3 and 3.

The number of negative revisions of EPS in the last 30 and 60days were 0 and 1 while for 90 and 120 days, the count was 1 and 1.

EPS revisions upgrade and downgrade in the last 18 days were 3 and 0 correspondingly.

Earnings Surprises

The mean EPS forecast immediately prior to the actual earnings release for the period ended 2 is $-0.29 based on 4 EPS estimates. The EPS reported on 2016-08-10 was $-0.48. The EPS surprise came at $-0.08, or -20%. The standard deviation of given EPS estimates was $0.06.

Quarterly Sales Estimates

The arithmetic mean of estimated annual sales of Argos Therapeutics, Inc. (NASDAQ:ARGS) is $0.316 and the median was $0.26. The estimate is reported by 3 analysts for the fiscal 2016.

The highest annual estimate is $0.49 and lowest sales target is $0.2. This results in a standard deviation of $0.153.

Almost 3 have revised sales forecast on upside over the past week and 3 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Nearly 3 have revised sales forecast on upside over the past month and 3 have downgraded forecasts. The mean estimate deviation from the past week is 0%.

Just about 3 have revised sales forecast on upside over the quarter and 3 have downgraded forecasts. The mean estimate deviation from the past week is -78.791%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 18 times, 1 visits today)